- Home
- / Yabao Pharmaceutical
Yabao Pharmaceutical
Stock Price
¥8.2
2023-09-20
Market Capitalization
¥6.4 B
2023-09-20
Revenue
¥2.6 B
FY, 2022
Yabao Pharmaceutical Summary
Company Summary
- Overview
- Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. It focuses on pediatrics, female health, cardiovascular diseases, and other therapeutic areas.
- Type
- Public
- Status
- Active
- Founded
- 1978
- HQ
- Yuncheng Shi, CN | view all locations
- Website
- http://www.yabao.com.cn/
- Cybersecurity rating
Table of Contents
Key People
Peng Wang, President of R&D
Sheldon Huang, General Manager
Operating MetricsView all
Products
300
Sep, 2023
Research and Development Centers
4
Sep, 2023
Production Bases
9
Sep, 2023
LocationsView all
4 locations detected
Yuncheng Shi, Shanxi Sheng HQ
China
No. 1, Industrial Avenue, Fenglingdu Economic Development Zone,
Beijing, Beijing Shi
China
11TH Floor, Building, 2 Tianhua N St
Yuncheng, Shanxi
China
Ruicheng County
Yuncheng Shi, Shanxi Sheng
China
Yongle South Road, Ruicheng County
Yabao Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2023)
- ¥793.7M
- Gross profit (Q1, 2023)
- ¥462.9M
- Net income (Q1, 2023)
- ¥111.5M
- Cash (Q1, 2023)
- ¥761.1M
- EBIT (Q1, 2023)
- ¥135.6M
- Enterprise value
- $6.2B